Gwangju Sang Moo Hospital, 181-7, Sangmujayu-ro, Gwangju 61948, Republic of Korea.
Neuromusculoskeletal Science Laboratory, 306 Jangsin-ro, Gwangju 62287, Republic of Korea.
Medicina (Kaunas). 2023 Jul 7;59(7):1268. doi: 10.3390/medicina59071268.
: Because most individuals with chronic back pain (CLBP) have no specific cause, it is usually described as central sensitization. Pain neuroscience education (PNE) in top-down pain control may be effective against carryover effects; however, this remains unclear. In this study, the carryover effect was qualitatively and quantitatively synthesized and analyzed. : Randomized controlled trials (RCTs) on PNE in individuals with CLBP were conducted using international databases until January 2023. Using RevMan5.4 provided by Cochrane, qualitative and quantitative analyses were performed with a risk of bias and meta-analysis, respectively. : Nine RCTs involving 1038 individuals with CLBP were included in the analysis. Four main results were identified: First, PNE had a short-term carryover effect on pain intensity (SMD = -1.55, 95% confidence interval [CI] = -2.59 to -0.50); second, PNE had a short-term carryover effect on pain catastrophizing (SMD = -2.47, 95% CI = -3.44 to -1.50); third, PNE had short- and long-term carryover effects on kinesiophobia (SMD = -3.51, 95% CI = -4.83 to -2.19); fourth, the appropriate therapeutic intensity of PNE for the pain intensity of individuals (SMD = -0.83, 95% CI = -1.60 to -0.07). : PNE has a short-term carryover effect on pain intensity and pain cognition in individuals with CLBP and a long-term carryover effect on kinesiophobia.
由于大多数慢性背痛(CLBP)患者没有特定的病因,因此通常将其描述为中枢敏化。自上而下的疼痛控制中的疼痛神经科学教育(PNE)可能对延续效应有效;然而,这一点仍不清楚。在这项研究中,对延续效应进行了定性和定量综合分析。
使用国际数据库,直到 2023 年 1 月,对患有 CLBP 的个体进行 PNE 的随机对照试验(RCT)。使用 Cochrane 提供的 RevMan5.4,分别进行风险偏倚和荟萃分析的定性和定量分析。
纳入了 9 项涉及 1038 名 CLBP 患者的 RCT 进行分析。确定了 4 个主要结果:首先,PNE 对疼痛强度具有短期延续效应(SMD = -1.55,95%置信区间 [CI] = -2.59 至 -0.50);其次,PNE 对疼痛灾难化具有短期延续效应(SMD = -2.47,95% CI = -3.44 至 -1.50);第三,PNE 对运动恐惧具有短期和长期延续效应(SMD = -3.51,95% CI = -4.83 至 -2.19);第四,PNE 对个体疼痛强度的适当治疗强度(SMD = -0.83,95% CI = -1.60 至 -0.07)。
PNE 对 CLBP 个体的疼痛强度和疼痛认知具有短期延续效应,对运动恐惧具有长期延续效应。